Leukemia Clinical Trials in Arizona

Showing 401-420 of 670 trials

Panobinostat in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma

NCT01261247

Panobinostat may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. This phase II trial is studying how well panobinostat works in treating patients with relapsed or refractory non-Hodgkin lymphoma

Adult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+18 more

Mayo Clinic41 participantsStarted Jan 2011

Scottsdale, Arizona, United States • Rochester, Minnesota, United States

COMPLETEDPHASE131 miles

A Phase 1 Study of Nivolumab (BMS-936558) in Subjects With Advanced or Recurrent Malignancies

NCT00730639

The purpose of this study is to determine the safety and effectiveness of MDX-1106 in patients with certain types of cancer. Another purpose is to determine how MDX-1106 is absorbed and distributed within the body, and how it's eventually eliminated.

Metastatic Castration-resistant Prostrate CancerRenal Cell CarcinomaMetastatic Melanoma+1 more

Bristol-Myers Squibb395 participantsStarted Oct 2008

Scottsdale, Arizona, United States • New Haven, Connecticut, United States • Tampa, Florida, United States +10 more locations

PreviousPage 21 of 34Next

Panobinostat in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma

A Phase 1 Study of Nivolumab (BMS-936558) in Subjects With Advanced or Recurrent Malignancies

Leukemia Trials in Other Cities

An Efficacy and Safety Study Of Pracinostat In Combination With Azacitidine In Adults With Acute Myeloid Leukemia

Combination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysplastic Syndromes

Double Cord Versus Haploidentical (BMT CTN 1101)

CMF Bone Stimulation as Adjunct to Surgical Treatment of Ankle Fractures

Avelumab in First-Line Maintenance Gastric Cancer (JAVELIN Gastric 100)

Long Term Safety and Efficacy Trial of Beclomethasone Dipropionate - Hydrofluoroalkane (BDP-HFA) 320 mcg in Allergic Rhinitis

Oral Immunotherapy for Desensitization in Children, Adolescents, and Young Adults With Hen Egg Allergy

A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia

Donor Bone Marrow Transplant With or Without G-CSF in Treating Young Patients With Hematologic Cancer or Other Diseases

A Study of LY3023414 in Participants With Advanced Cancer

Safety Study of MGA271 in Refractory Cancer

A Study of Venetoclax in Combination With Cobimetinib and Venetoclax in Combination With Idasanutlin in Patients With Relapsed or Refractory Acute Myeloid Leukemia Who Are Not Eligible for Cytotoxic Therapy

Collect and Assess Tissue Samples From Subjects With Hematologic Malignancy

Study of PTC299 (Emvododstat) in Relapsed/Refractory Acute Leukemias

Lenalidomide in Treating Older Patients With Acute Myeloid Leukemia

Study to Evaluate Dupilumab Monotherapy in Pediatric Patients With Peanut Allergy

A Study Evaluating the Safety and Pharmacokinetics of Atezolizumab Administered in Combination With Hu5F9-G4 to Patients With Relapsed and/or Refractory Acute Myeloid Leukemia

Enoblituzumab (MGA271) in Children With B7-H3-expressing Solid Tumors

Other Conditions in Arizona